Cullinan Therapeutics, Inc. · NASDAQ:CGEM

Kynam Capital Management, LP reported a 5.27% stake in Cullinan Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Mar 4, 2026

Kynam Capital Management, LP reported a 5.27% stake in Cullinan Therapeutics, Inc., 3,114,132 shares, as a passive investor on Dec 31, 2025. Filed Mar 4, 2026 (Schedule 13G).

Stake
5.27%
Shares
3,114,132
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Kynam Capital Management, LP5.27%3,114,132
Kynam Capital Management GP, LLC5.27%3,114,132
Yue Tang5.27%3,114,132

Source

View original at SEC

Related